ArticleInternational cancer conference journal2025
Low-dose oral cyclophosphamide with or without bevacizumab treatment in patients with recurrent ovarian and cervical cancer before best supportive care.
Yusuke Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.